Drug Approval | May 12, 2023
USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time
‘Fibrotic disease’ is a term that covers a range of diseases characterized by uncontrolled and progressive fibrosis,
A special technique of jet injection is used to make vaccination almost painless and totally needleless.
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Roflumilast reduces inflammation in the lungs that leads to chronic obstructive pulmonary disease (COPD)
mRNA-4157 (V940) in combination with KEYTRUDA reduced the risk of recurrence or death by 44% compared to KEYTRUDA alone in stage III/IV melanoma patients
Alpenglow has created an end-to-end 3D spatial biology solution including patented high-throughput 3D imaging
Azithromycin Tablets USP, 500 mg had annual sales of US $20 million in the United States
Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039
Getinge has a strong market share in India within several product segments
Subscribe To Our Newsletter & Stay Updated
